ArticleFrontiers in pharmacology2024
Proteomics study the potential targets for Rifampicin-resistant spinal tuberculosis.
Yanling Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleFrontiers in pharmacology2024
Yanling Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.